LIMAF
Price
$33.65
Change
-$1.50 (-4.27%)
Updated
Mar 4 closing price
Capitalization
3.55B
MBUMY
Price
$6.75
Change
-$0.09 (-1.32%)
Updated
Jan 15 closing price
Capitalization
1.87B
Ad is loading...

LIMAF vs MBUMY

Header iconLIMAF vs MBUMY Comparison
Open Charts LIMAF vs MBUMYBanner chart's image
Linamar
Price$33.65
Change-$1.50 (-4.27%)
Volume$81.36K
Capitalization3.55B
Mabuchi Motor
Price$6.75
Change-$0.09 (-1.32%)
Volume$405
Capitalization1.87B
LIMAF vs MBUMY Comparison Chart
Loading...
View a ticker or compare two or three
VS
LIMAF vs. MBUMY commentary
Mar 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIMAF is a Hold and MBUMY is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 06, 2025
Stock price -- (LIMAF: $33.65 vs. MBUMY: $6.75)
Brand notoriety: LIMAF and MBUMY are both not notable
Both companies represent the Auto Parts: OEM industry
Current volume relative to the 65-day Moving Average: LIMAF: 350% vs. MBUMY: 115%
Market capitalization -- LIMAF: $3.55B vs. MBUMY: $1.87B
LIMAF [@Auto Parts: OEM] is valued at $3.55B. MBUMY’s [@Auto Parts: OEM] market capitalization is $1.87B. The market cap for tickers in the [@Auto Parts: OEM] industry ranges from $52.56B to $0. The average market capitalization across the [@Auto Parts: OEM] industry is $5.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIMAF’s FA Score shows that 1 FA rating(s) are green whileMBUMY’s FA Score has 1 green FA rating(s).

  • LIMAF’s FA Score: 1 green, 4 red.
  • MBUMY’s FA Score: 1 green, 4 red.
According to our system of comparison, MBUMY is a better buy in the long-term than LIMAF.

Price Growth

LIMAF (@Auto Parts: OEM) experienced а -9.74% price change this week, while MBUMY (@Auto Parts: OEM) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Auto Parts: OEM industry was -3.58%. For the same industry, the average monthly price growth was -0.37%, and the average quarterly price growth was +4.69%.

Industries' Descriptions

@Auto Parts: OEM (-3.58% weekly)

OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.

FUNDAMENTALS
Fundamentals
LIMAF($3.55B) has a higher market cap than MBUMY($1.87B). MBUMY has higher P/E ratio than LIMAF: MBUMY (17.89) vs LIMAF (10.99). MBUMY YTD gains are higher at: -11.533 vs. LIMAF (-14.810). MBUMY has higher annual earnings (EBITDA): 9.94B vs. LIMAF (1.09B). MBUMY has more cash in the bank: 99.3B vs. LIMAF (891M). MBUMY has less debt than LIMAF: MBUMY (1.14B) vs LIMAF (1.37B). MBUMY has higher revenues than LIMAF: MBUMY (160B) vs LIMAF (8.43B).
LIMAFMBUMYLIMAF / MBUMY
Capitalization3.55B1.87B190%
EBITDA1.09B9.94B11%
Gain YTD-14.810-11.533128%
P/E Ratio10.9917.8961%
Revenue8.43B160B5%
Total Cash891M99.3B1%
Total Debt1.37B1.14B120%
FUNDAMENTALS RATINGS
LIMAF vs MBUMY: Fundamental Ratings
LIMAF
MBUMY
OUTLOOK RATING
1..100
5046
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
29
Undervalued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
6373
PRICE GROWTH RATING
1..100
8274
P/E GROWTH RATING
1..100
9134
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LIMAF's Valuation (25) in the null industry is in the same range as MBUMY (29). This means that LIMAF’s stock grew similarly to MBUMY’s over the last 12 months.

LIMAF's Profit vs Risk Rating (99) in the null industry is in the same range as MBUMY (100). This means that LIMAF’s stock grew similarly to MBUMY’s over the last 12 months.

LIMAF's SMR Rating (63) in the null industry is in the same range as MBUMY (73). This means that LIMAF’s stock grew similarly to MBUMY’s over the last 12 months.

MBUMY's Price Growth Rating (74) in the null industry is in the same range as LIMAF (82). This means that MBUMY’s stock grew similarly to LIMAF’s over the last 12 months.

MBUMY's P/E Growth Rating (34) in the null industry is somewhat better than the same rating for LIMAF (91). This means that MBUMY’s stock grew somewhat faster than LIMAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRHSX81.93N/A
N/A
T. Rowe Price Health Sciences
SDGTX120.14N/A
N/A
DWS Capital Growth Institutional
SDYYX16.69N/A
N/A
SEI Dynamic Asset Allocation Y (SIMT)
PAGDX101.12N/A
N/A
Permanent Portfolio Aggressive Growth A
WEMCX6.15-0.03
-0.49%
Allspring Emerging Growth C

LIMAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIMAF has been loosely correlated with MGA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if LIMAF jumps, then MGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMAF
1D Price
Change %
LIMAF100%
-4.27%
MGA - LIMAF
56%
Loosely correlated
-3.37%
LEA - LIMAF
49%
Loosely correlated
-2.42%
AXL - LIMAF
48%
Loosely correlated
-4.21%
GT - LIMAF
48%
Loosely correlated
-4.19%
DAN - LIMAF
44%
Loosely correlated
-2.75%
More

MBUMY and

Correlation & Price change

A.I.dvisor tells us that MBUMY and KOTMF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBUMY and KOTMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBUMY
1D Price
Change %
MBUMY100%
N/A
KOTMF - MBUMY
8%
Poorly correlated
N/A
MRETF - MBUMY
8%
Poorly correlated
-2.39%
KOTMY - MBUMY
8%
Poorly correlated
-0.08%
LIMAF - MBUMY
7%
Poorly correlated
-4.27%
KNBHF - MBUMY
4%
Poorly correlated
-3.44%
More